MAVIRET Coated granules Ref.[51252] Active ingredients: Glecaprevir and Pibrentasvir

Source: European Medicines Agency (EU)  Revision Year: 2023  Publisher: AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany

Product name and form

Maviret 50 mg/20 mg coated granules in sachet.

Pharmaceutical Form

Coated granules.

Pink and yellow granules.

Qualitative and quantitative composition

Each sachet contains 50 mg glecaprevir and 20 mg pibrentasvir.

Excipient with known effect: Each sachet of coated granules contains 26 mg of lactose (as monohydrate) and 4 mg propylene glycol.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Glecaprevir and Pibrentasvir

Glecaprevir/Pibrentasvir is a fixed-dose combination of two pan-genotypic, direct-acting antiviral agents, glecaprevir (NS3/4A protease inhibitor) and pibrentasvir (NS5A inhibitor), targeting multiple steps in the HCV viral lifecycle.

List of Excipients

Granule core:

Copovidone
Tocofersolan
Propylene glycol monocaprylate
Colloidal silicon dioxide
Croscarmellose sodium (in the glecaprevir granules only)
Sodium stearyl fumarate

Granule coating:

Hypromellose (E464)
Lactose monohydrate
Titanium dioxide
Macrogol
Iron oxide red (E172)
Iron oxide yellow (E172)

Pack sizes and marketing

Maviret coated granules are supplied in polyethylene terephthalate (PET)/aluminium/polyethylene film sachets in cartons. Each carton contains 28 sachets.

Marketing authorization holder

AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany

Marketing authorization dates and numbers

EU/1/17/1213/003

Date of first authorisation: 26 July 2017
Date of latest renewal: 22 March 2022

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.